Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy.

Part of Teva Pharmaceutical Industries Ltd., Pharmachemie BV (doing business as Teva Pharmachemie BV) is a company headquartered in Haarlem, the Netherlands, that produces pharmanceutical products.

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Almirall SA is a global biopharmaceutical company, which is focused on skin health. It engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The firm operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research and Development Activity, Therapeutic Area of Dermatology in the United States, and Corporate Management and Results not Allocated Assigned to Other Segments. Its products include treatments for respiratory, autoimmune, dermatological, and gastrointestinal diseases. The company was founded in 1943 and is headquartered in Barcelona, Spain.

Yamanouchi Pharmaceutical Co. Ltd. manufactures and markets drugs, quasi-drugs and medical devices. It used to promote collaboration with other pharmaceutical companies as well as bioventure companies and academia to raise the quality and speed of its R&D activities. It was founded in 1923. The company was headquartered in Tokyo, JP

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Tianjin Jinyao Group Co. Ltd. is a Chinese private company located in Tianjin. The firm manufactures pharmaceutical products.

Tianjin Lisheng Pharmaceutical Co., Ltd. principally engages in the production and sale of chemical tablets, hard capsules, drop pills, freeze-dried powder injections, water injections, and active pharmaceutical ingredients. The company was founded in 1951 and is headquartered in Tianjin, China.

Siqiao Ruite Pharmaceutical Co., Ltd., established on 2012-08-23, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Drug retail;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Information Consulting Service(Not including licensing information consulting services);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

MAP Pharmaceuticals, Inc., a development stage company, focuses on developing novel inhalation therapies for respiratory and systemic diseases. It has various proprietary product candidates in clinical development, including Unit Dose Budesonide for pediatric asthma in children from six months to eight years of age and MAP0004 for migraine. The company's product portfolio also includes MAP0005 for the treatment of adolescent and adult asthma, and chronic obstructive pulmonary disease; and MAP0001 for the treatment of Type 1 and Type 2 diabetes via pulmonary delivery using its Tempo inhaler. MAP Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Mountain View, California.

Chemo Research SL is a Spanish private company. The firm engages in research and development in natural sciences & techniques.

Joincare Pharmaceutical Industry Group Co., Ltd (hereinafter called Joincare Pharmaceutical Group), growing out of Shenzhen Taitai Healthcare Food Co., Ltd, was established by the board chairman Zhu Baoguo in the year 1992. The leading position in the healthcare industry was established by “Taitai Oral Liquid”. The strategy of the company was in transition to enter pharmaceutical industry in 1995, and was renamed Shenzhen Taitai Pharmaceutical Co., Ltd. This transformation was successfully completed by the acquisition of Shenzhen Haibin Pharmaceutica Co., Ltd in 1997. In 1999, the company was renamed Shenzhen.

Shanghai Fangyu Health Medicine Technology Co., Ltd., established on 2013-09-10, Business scope includes new pharmaceutical products,Health products,medical instruments,Diagnostic reagents,Research and development of pharmaceutical intermediates,and provide relevant technical advice,Technical Services,technology transfer. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Mexichem Fluor SA de CV manufactures hydrofluoric acid. The company is headquartered in San Luis Potosi, Mexico.

Yili Pharmaceutical Co., Ltd., established on 2008-12-26, Business range includes tablet,Capsules(Contains cephalosporins),Granules,mixture,Liniment,syrup,API,Pretreatment and extraction of traditional Chinese medicine(Oral preparations)Production,Sales;real estate herbal medicine(Does not contain Chinese herbal medicine)buy and sell;drinks(other beverages)Production,Sales;Medical device production,Sales;food business;Domestic Trade(Business scope involves law,prohibited by law,Not allowed to operate;subject to approval,Do not operate without approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)